Market Overview

Global Small Animal Imaging (In-vivo) Market Size, Share & Trends Analysis 2012-2018 & 2018-2022 - Focus on Optical Imaging, Micro-Magnetic Resonance Imaging, Nuclear Imaging -


The "Small
Animal Imaging (In-vivo) Market Size, Share & Trends Analysis Report By
Technology (Optical Imaging, Micro-Magnetic Resonance Imaging, Nuclear
Imaging), By Application, And Segment Forecasts, 2012 - 2022"

report has been added to's

The global small animal imaging (In-Vivo) market size is expected to
reach 2.7 billion by 2022, progressing at a CAGR of 9.0% during the
forecast period.

Rising number of medical conditions requiring precise research for
development of treatment options is anticipated to stoke the demand for
small animal imaging over the forecast period.

Importance of these devices in applications such as defining mechanism
of action, drug receptor targeting, and epigenetic research studies are
projected to provide substantial growth for the market. Some of the
major drivers of small animal imaging (in-vivo) market are technical
innovations such as high-resolution MRI with other modalities, growing
number of research and pharmaceutical organizations, increasing
investments of CROs in pre-clinical studies, and rising adoption of
multi-functional pre-clinical imaging.

Some of the key players are Promega Corporation, Inc.; Miltenyi Biotec
GmbH; Life Technologies Corporation; FujiFilm Holding Corporation;
Siemens AG; Thermo Fisher Scientific; Bruker Corporation; PerkinElmer
Inc.; and Aspect Imaging Ltd.

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Small Animal Testing (In-Vivo) Industry Outlook

Chapter 4. Small Animal Imaging (In-Vivo) Technology Outlook

Chapter 5. Small Animal Imaging (In-Vivo) Application Outlook

Chapter 6. Small Animal Imaging (In-Vivo) Regional Outlook

Chapter 7. Competitive Landscape

  • Thermo Fisher Scientific
  • Siemens AG
  • Life Technologies Corporation
  • Bruker Corporation
  • PerkinElmer, Inc
  • Aspect Imaging Ltd.
  • Promega Corporation

For more information about this report visit

View Comments and Join the Discussion!